Pfizer and J&J end development of Alzheimer's drug
18:17 EDT 6 Aug 2012 | PharmPro
Pfizer Inc. and Johnson & Johnson say they are ending development of a once-promising drug designed to treat Alzheimer's disease after the treatment failed in two late-stage clinical trials.The companies say their drug bapineuzumab (BAP'eh-new-ZOO'm..
Original Article: Pfizer and J&J end development of Alzheimer's drug
More From BioPortfolio on "Pfizer and J&J end development of Alzheimer's drug"
Biotech & Healthcare Channels
World News
Life Science Events
Corporate Database
Market Reports
Categories
Search BioPortfolio:
